TherVacB, a novel therapeutic vaccine to combat chronic hepatitis B, entered the first clinical trial. The vaccine was designed and developed under the leadership of Helmholtz Munich. This phase Ia
Symposium
Klinikum der Goethe Universität Frankfurt Theodor-Stern-Kai 7 I Hörsaal 23-3 60590Frankfurt Germany
Professor Gerd Sutter has died at the age of 61. His pioneering work on the development of MVA vaccines against measles, MERS-CoV and West Nile virus, among others, had a major impact on modern
Despite decades of research, there is still no vaccine that protects against HIV infection. It is currently assumed, however, that such a vaccine can only be effective if it also produces so-called
Every year at least 700,000 people die as a result of infection with antibiotic-resistant bacteria—a figure which according to WHO forecasts could rise to ten million people by 2050 without new
New protection against severe respiratory diseases: Experts from eleven medical societies and institutions—including researchers from the German Center for Infection Research—are now calling on people
